Adage Capital Partners GP »

Bridgebio Pharma shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.5M 276k 30.92
2022-12-31 $2.9M 378k 7.62
2022-09-30 $994k 100k 9.94

More positions owned by Adage Capital Partners GP

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Hess (HES)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Tesla Motors (TSLA)
Merck & Co (MRK)
Abbvie (ABBV)

View all positions for Adage Capital Partners GP

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
BlackRock
Aisling Capital Management
Laurion Capital Management
UBS Group
Frazier Life Sciences Management
Henderson Group
Cormorant Asset Management
Pictet Asset Management Holding SA
Geode Capital Management
Lord, Abbett & Co
Alliancebernstein
FMR

View all funds holding Bridgebio Pharma